# Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-reducing-the-risk-of-transfusion-transmitted-babesiosis-guidance-for-industry/027542ba-a0a9-4d9e-a1d0-46e29312bcf5

> FDA guidance document: Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis:  Guidance for Industry. Issue date: May 09, 2019. Get complete insights and analysis.

---

## Details

- Title: Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2019-05-09
- Last Changed: 2019-05-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-2478">FDA-2018-D-2478</a>

## Related Documents

- [Considerations for the Development of Dried Plasma Products Intended for Transfusion:   Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-the-development-of-dried-plasma-products-intended-for-transfusion-guidance-for-industry/c0c693ab-7392-4bad-b4c9-de122a24ced4)
- [Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/standards-development-and-the-use-of-standards-in-regulatory-submissions-reviewed-in-the-center-for-biologics-evaluation-and-research-guidance-for-industry/51d68e06-fcf7-4a0e-b596-a949b93aad30)
- [Human Gene Therapy for Hemophilia:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-hemophilia-guidance-for-industry/bceafce9-c9f0-4137-9ca5-071464212a06)